<code id='2C8E5390C4'></code><style id='2C8E5390C4'></style>
    • <acronym id='2C8E5390C4'></acronym>
      <center id='2C8E5390C4'><center id='2C8E5390C4'><tfoot id='2C8E5390C4'></tfoot></center><abbr id='2C8E5390C4'><dir id='2C8E5390C4'><tfoot id='2C8E5390C4'></tfoot><noframes id='2C8E5390C4'>

    • <optgroup id='2C8E5390C4'><strike id='2C8E5390C4'><sup id='2C8E5390C4'></sup></strike><code id='2C8E5390C4'></code></optgroup>
        1. <b id='2C8E5390C4'><label id='2C8E5390C4'><select id='2C8E5390C4'><dt id='2C8E5390C4'><span id='2C8E5390C4'></span></dt></select></label></b><u id='2C8E5390C4'></u>
          <i id='2C8E5390C4'><strike id='2C8E5390C4'><tt id='2C8E5390C4'><pre id='2C8E5390C4'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:641
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          A disappointing year of Humira biosimilars
          A disappointing year of Humira biosimilars

          DavidJ.Phillip/APIt’sbeenoneyearsincethelaunchofthefirstadalimumabbiosimilarforHumiraintheUnitedStat

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Medical mystery: When a cough is not just a cough

          MollyFergusonforSTATWhenCherylDaiglestartedcoughinginFebruary2013,shechalkedituptothesneezingandsnif